An uptick in issuance as issuers begin to test the market.
Quiet start to the year...
ECM Annual Recap.
Modest December caps off lackluster year for US ECM.
All sectors were active as market rally continues.
Biotech issuance resilient amidst market volatility.
Growing macroeconomic uncertainty thwarts a recovery in ECM issuance in Setpember.